MetLife Investment Management’s Vericel Corp VCEL Stock Holding History

MetLife Investment Management’s Portfolio VCEL Stock Details VCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Buy	30,049 +1,808	+6%	+$65.1K	0.01%	1369
2026 Q1	$909K	Sell	28,241 -201	-0.7%	-$7.14K	﹤0.01%	1448
2025 Q4	$1.02M	Sell	28,442 -1,469	-5%	-$54K	0.01%	1416
2025 Q3	$941K	Hold	29,911	–	–	﹤0.01%	1483
2025 Q2	$1.27M	Buy	29,911 +724	+2%	+$30.1K	0.01%	1188
2025 Q1	$1.3M	Sell	29,187 -422	-1%	-$22.7K	0.01%	1236
2024 Q4	$1.63M	Buy	29,609 +1,929	+7%	+$97.6K	0.01%	1164
2024 Q3	$1.17M	Hold	27,680	–	–	0.01%	1310
2024 Q2	$1.27M	Buy	27,680 +3,242	+13%	+$153K	0.01%	1220
2024 Q1	$1.27M	Sell	24,438 -1,769	-7%	-$77.5K	0.01%	1167
2023 Q4	$933K	Hold	26,207	–	–	0.01%	1335
2023 Q3	$878K	Hold	26,207	–	–	0.01%	1302
2023 Q2	$985K	Buy	26,207 +656	+3%	+$21.6K	0.01%	1281
2023 Q1	$749K	Hold	25,551	–	–	0.01%	1391
2022 Q4	$673K	Sell	25,551 -896	-3%	-$21.3K	0.01%	1452
2022 Q3	$614K	Hold	26,447	–	–	0.01%	1487
2022 Q2	$666K	Hold	26,447	–	–	0.01%	1470
2022 Q1	$1.01M	Buy	26,447 +9,717	+58%	+$351K	0.01%	1314
2021 Q4	$657K	Hold	16,730	–	–	0.01%	1349
2021 Q3	$816K	Hold	16,730	–	–	0.01%	1236
2021 Q2	$878K	Sell	16,730 -1,902	-10%	-$108K	0.01%	1238
2021 Q1	$1.04M	Hold	18,632	–	–	0.01%	1140
2020 Q4	$575K	Hold	18,632	–	–	0.01%	1419
2020 Q3	$345K	Hold	18,632	–	–	﹤0.01%	1559
2020 Q2	$257K	Hold	18,632	–	–	﹤0.01%	1751
2020 Q1	$171K	Hold	18,632	–	–	﹤0.01%	1785
2019 Q4	$324K	Hold	18,632	–	–	﹤0.01%	1699
2019 Q3	$282K	Hold	18,632	–	–	﹤0.01%	1743
2019 Q2	$352K	Sell	18,632 -37,264	-67%	-$635K	﹤0.01%	1697
2019 Q1	$978K	Buy	55,896 +37,264	+200%	+$681K	﹤0.01%	1678
2018 Q4	$324K	Hold	18,632	–	–	﹤0.01%	1625
2018 Q3	$264K	Hold	18,632	–	–	﹤0.01%	1933
2018 Q2	$181K	Buy	+18,632	New	+$232K	﹤0.01%	1966

Other funds holding VCEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MetLife Investment Management's VCEL Position: Q2 2026 in Review

MetLife Investment Management increased its Vericel Corp (VCEL) stake by 6.4% in Q2 2026, buying an estimated $65.1K and bringing the position to 30,049 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #1369.

MetLife Investment Management first reported a position in VCEL in Q2 2018 and has held it in 33 quarters since. The position peaked at $1.63M in Q4 2024. 319 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

MetLife Investment Management held 30,049 shares of Vericel Corp worth $1.34M as of Q2 2026.
MetLife Investment Management bought 1,808 Vericel Corp shares in Q2 2026, an estimated $65.1K.
Vericel Corp made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1369 holding.
MetLife Investment Management first reported a position in Vericel Corp in Q2 2018 and has held it in 33 quarters since.
MetLife Investment Management's Vericel Corp position peaked at $1.63M in Q4 2024.
319 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.